EXDENSUR
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EXDENSUR, covering 2025-12-16 to 2026-08-13. Get the full timeline:
Most recent: EMA Authorised: Exdensur (depemokimab) — GlaxoSmithKline Trading Services Limited